arrow
W

Werner Engl

takeda pharmaceutical company ltd.
H指数:19
被引数:2,451

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term safety and efficacy results from the phase 3b, open-label, multicentre Continuation study of rurioctocog alfa pegol for prophylaxis in previously treated patients with severe haemophilia A

Ruriocog alfa pegol用于先前治疗的严重血友病A患者预防的3b期,开放标签,多中心持续研究的长期安全性和有效性结果

2020-06-2817
OAAI
Local Adverse Reaction Rates Decreased over Time during Treatment with Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (IGHy) in Patients with Primary Immunodeficiency Disorders in the IGHy Phase 3 Studies
2016-02-011
OAAI